Find Practical Strategies to Accelerate Your Biologics to Market:
More Efficient Cell Line, Cell Culture and Media Development
New Techniques for Analytical, Quality and Comparability
State-of the-Art Methods for Biomanufacturing, Facilities & GMP Compliance
Accelerated IND Filings in China
Overcome Downstream Processing and Purification Bottlenecks
Viral Safety for Biologicals to Protect Your Operations
Compare Data from mAbs, Vaccines, Biosimilars, Fusions and more
"This conference is great. It's valuable for anyone who what wants to learn about the latest progress and future trends in the field."- Hezhong Liu, Vice President, Beijing Hua'an Innovation Biotechnologies, China
Why You Should Attend
This is your gateway to meet and network with Chinese/Asian drug developers and contract manufacturers to understand where they stand in the field of processing capabilities, as well as find potential business partners and collaborators to develop biosimilars, biobetters, novel biologics or vaccines.
This is your opportunity to learn technical know-how and practical solutions from the experienced scientists and engineers from around the world, as well as hear how to trouble-shoot problems and avoid pitfalls in the quest for higher yield and better quality.
"At this conference, I got information on all aspects of the biologics industry. The emphasis on comparisons between the biologics industry in China and the US was especially useful."- Huilin Zhu, Senior Scientist, Cell Culture PD, Wuxi Apptec, China
Copyright IBC Life Sciences, a part of Informa Life Sciences Group.Phone: 800.390.4078Email: firstname.lastname@example.org